Thiara Parvinder 4

What Happened
Thiara Parvinder, a director of Zura Bio Ltd (ZURA), was granted a derivative equity award covering 38,823 shares on January 23, 2026. The transaction is recorded on the Form 4 as an award/acquisition at $0 (typical for equity grants) — this is a compensation-related equity grant, not an open-market purchase.

Key Details

• Transaction date: January 23, 2026; Form 4 filed January 27, 2026 (timely filing).
• Transaction type/code: A (award/acquisition) of a derivative security (option). Price shown: $0.00 in the filing.
• Number of shares/options: 38,823 shares (derivative award).
• Post-transaction beneficial ownership: Not specified in the excerpt of the filing.
• Footnote: The option vests in 12 substantially equal monthly installments over one year from Jan 23, 2026; any remaining unvested portion will vest the day before the next annual shareholders meeting, subject to continued service.
• Filing status: Timely (filed within required reporting window).

Context
This was an equity compensation grant (an option award) rather than a market purchase or sale. Such awards are common for company insiders as part of compensation or retention and do not by themselves indicate immediate buying or selling in the market. The award vests monthly over a year, so any future exercises or sales would be reported in later filings.